USPTO serial 98860507
PADAGIS NALOXONE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 2, 2026
- Examiner
- POLLACK, ALISON FRIEDBERG
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PADAGIS NALOXONE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
ALLEGAN, MI, US
ALLEGAN, MI, US
ALLEGAN, MI, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrea M. Porterfield
Andrea M. Porterfield Polsinelli PCPO Box 140310Kansas City, MO 64114-0310United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicinal pharmaceutical preparations used as a narcotic antagonist for the treatment of opioid overdose; pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists for the treatment of opioid overdose; pharmaceutical and pharmaceutical drug preparations for use in treatment of opiate, opioid or narcotic overdose; intranasal drug delivery devices, spray pump devices for nasal delivery, and devices for nasal delivery, all being drug delivery agents in nasal spray form that facilitate the delivery of pre-filled pharmaceuticals preparations, namely, opioid antagonists and narcotic antagonists and pharmaceutical and pharmaceutical drug preparations for use in treatment of opiate, opioid or narcotic overdose; nasal spray preparations; Medical kits, namely opioid overdose response kits comprising pharmaceutical preparations for use in treatment of opiate, opioid or narcotic overdose and also including carrying cases, training kits containing nasal spray bottles sold empty, and storage cabinets for medical kits of intranasal drug delivery devices | ACTIVE | Oct 10, 2024 |
| 020 | Medicine cabinets | ACTIVE | Oct 10, 2024 |
| 035 | Online retail store services featuring opioid antagonists, narcotic antagonists, and pharmaceutical and drug preparations for use in the treatment of opiate, opioid or narcotic overdose; online retail pharmacy services | ACTIVE | Oct 10, 2024 |
| 044 | Providing medical and health information services; providing a website for patients, medical professionals, and pharmacists featuring medical information in the fields of health, medicine, opioids and narcotics, opioid antagonists and narcotic antagonists, drug overdoses, and emergency medical tips; providing a website featuring pharmaceutical drug medical information relating to diagnostic, prophylactic and therapeutic properties of naloxone, opioid antagonists and narcotic antagonists | ACTIVE | Oct 10, 2024 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PADAGIS US LLC
- Other trademarks owned by PADAGIS US LLC
- Other trademarks owned by PADAGIS US LLC
- Other trademarks in Class 005
- Other trademarks in Class 020
- Other trademarks in Class 035
- Other trademarks in Class 044
- Similar marks named PADAGIS NALOXONE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 2, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 2, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 11, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| May 11, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 11, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 11, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 23, 2025 | IUAF | USE AMENDMENT FILED | — |
| Dec 23, 2025 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Nov 4, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 9, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 9, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 3, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 8, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 8, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 8, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 8, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 8, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 28, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 28, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 28, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 14, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 14, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 14, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 13, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| May 11, 2025 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| May 11, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 19, 2024 | NWAP | NEW APPLICATION ENTERED | — |